NCT05065411 2024-02-26
VERU-024
Veru Inc.
Phase 3 Terminated
Clinical Trials
5 trialsNCT04460807 2024-02-12
EXPERT
Ente Ospedaliero Ospedali Galliera
Phase 3 Terminated
NCT04869943 2024-01-26
ARTEST
Veru Inc.
Phase 3 Terminated
NCT01303679 2023-09-06
1st Line Treatment of Bevacizumab-Taxane vs Bevacizumab-Exemestane in Metastatic Breast Cancer
ARCAGY/ GINECO GROUP
Phase 3 Terminated
NCT00810706 2008-12-18
ATENA
Hellenic Breast Surgeons Society
Phase 3 Terminated